文献速递关节外科

美国全关节置换术后院内静脉血栓栓塞的发生率与经济负担

The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
PubMed 文献 · J Arthroplasty · 2016-10-21

基于美国全国住院患者样本2002至2011年数据,分析全髋与全膝关节置换术后院内静脉血栓栓塞(VTE)的发生率、住院时长与费用。翻修关节置换的院内VTE发生率高于初次置换(2.5% vs 1.6%,P < .0001)。近十年VTE总体发生率下降但肺栓塞发生率保持相对稳定,相关费用显著增加。

要点

  • 翻修关节置换院内VTE发生率高于初次置换(2.5% vs 1.6%,P < .0001)。
  • 初次全髋置换院内VTE中位率0.59%(0.55%-0.63%),初次全膝置换1.01%(0.94%-1.08%)。
  • 合并VTE患者住院时间更长(初次全膝中位7天 vs 3天;初次全髋中位6天 vs 3天,P < .0001)。

核心结论

  • 基于全国住院患者样本数据库分析,全关节置换术后院内深静脉血栓发生率近十年似乎下降,而肺栓塞发生率保持恒定。
  • 作者认为这可能表明美国骨科医师学会当前的VTE预防建议足以预防深静脉血栓且不增加肺栓塞发生率,或因为深静脉血栓成为「never」事件而减少了机构筛查与报告。

研究设计与样本

  • 使用全国住院患者样本(Nationwide Inpatient Sample),依据国际疾病分类第九版手术操作编码,估算2002至2011年全髋置换、全膝置换与VTE事件总数。
  • 获取院内深静脉血栓与肺栓塞发生率、相关住院时长以及当前与预测的院内费用。

主要发现

  • 翻修关节置换的院内VTE发生率高于初次关节置换(2.5% vs 1.6%,P < .0001)。
  • 初次全髋置换的院内VTE中位率为0.59%(0.55%-0.63%),初次全膝置换为1.01%(0.94%-1.08%)。
  • 翻修全髋置换的VTE事件多于翻修全膝置换(1.35% [1.25%-1.46%] vs 1.16% [1.07%-1.26%])。
  • 合并VTE患者住院时间更长(初次全膝置换中位7天 vs 3天;初次全髋置换中位6天 vs 3天,P < .0001)。
  • 近十年VTE总体发生率下降,但肺栓塞发生率保持相对恒定,且VTE相关费用显著增加。

关键数值与推荐

  • 翻修关节置换院内VTE发生率2.5%,初次关节置换1.6%(P < .0001)。
  • 初次全髋置换院内VTE中位率0.59%(0.55%-0.63%),初次全膝置换1.01%(0.94%-1.08%)。
  • 翻修全髋置换VTE发生率1.35%(1.25%-1.46%),翻修全膝置换1.16%(1.07%-1.26%)。
  • 合并VTE的初次全膝置换患者住院中位7天 vs 无VTE者3天;初次全髋置换中位6天 vs 3天(P < .0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) is a potentially preventable and costly complication after total hip arthroplasty (THA) and total knee arthroplasty (TKA). The in-hospital incidence and economic burden of VTE following total joint arthroplasty (TJA) in the United States is unknown. The aim of this study was to examine this issue. METHODS: The Nationwide Inpatient Sample was used to estimate the total number of THA, TKA, and VTE events using International Classification of Diseases, Ninth Revision procedure codes from years 2002 to 2011. The rate of in-hospital deep vein thrombosis (DVT) and pulmonary embolism (PE), associated length of hospitalization, and current and projected in-hospital charges were obtained. RESULTS: Revision arthroplasties had higher rates of in-hospital VTE compared to primary TJAs (2.5% vs 1.6%, P < .0001). Among primary TJAs, the median rate of in-hospital VTE was 0.59% (0.55%-0.63%) for primary THA and 1.01% (0.94%-1.08%) for primary TKA. Revision THAs developed more VTE events compared to revision TKAs (1.35% [1.25%-1.46%] vs 1.16% [1.07%-1.26%]). Patients with a VTE have longer hospitalizations (median primary TKA: 7 vs 3; median primary THA: 6 vs 3, P < .0001). The overall rate of VTE decreased over the last decade; however, the PE rates have remained relatively constant. Moreover, the associated costs with VTE events have increased significantly over the last decade. CONCLUSION: Based on the analysis of the Nationwide Inpatient Sample database, the rate of in-hospital DVT following TJA appears to have declined over the last decade while the incidence of PE has remained constant. This may indicate that the current recommendations by the American Academy of Orthopaedic Surgeons for VTE prophylaxis are adequate for preventing DVT without increasing the rate of PE or that institutional screening and reporting of DVT has been reduced because DVTs became a "never" event.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Shahi A, Chen AF, Tan TL, et al. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States. J Arthroplasty. 2016. PMID: 27866951. doi:10.1016/j.arth.2016.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。